Publications by authors named "Alieu Amara"

Claim this Profile
D
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.
Michael Abouyannis, Yvonne K Nyambura, Samson Ngome, Debra Riako, Jennifer Musyoki, Alieu Amara

EBioMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MS.
Beth Thompson, Sujan Dilly-Penchala, Alieu Amara, Helen Reynolds, Saye Khoo

Bioanalysis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.
Carolina Herrera, Jennifer Serwanga, Laura Else, Lebina Limakatso, Daniel Opoka, Amara Alieu

EBioMedicine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021.
Victoria Maddox, Claire Reynolds, Alieu Amara, Laura Else, Susan R Brailsford

Euro Surveill· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Richard FitzGerald, Laura Dickinson, Laura Else, Thomas Fletcher, Colin Hale, Alieu Amara

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry.
Adeniyi Olagunju, Jacinta Nwogu, Oluwasegun Eniayewu, Shakir Atoyebi, Alieu Amara

Wellcome Open Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019.
Heli Harvala, Claire Reynolds, Samreen Ijaz, Vicki Maddox, Sujan Dilly Penchala, Alieu Amara

Sex Transm Infect· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
Lauren E Walker, Richard FitzGerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Alieu Amara

Clin Pharmacol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva.
Alieu Amara, Sujan Dilly Penchala, Laura Else, Colin Hale, Richard FitzGerald

J Pharm Biomed Anal· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.
Laura Dickinson, Stephen Walimbwa, Yashna Singh, Julian Kaboggoza, Kenneth Kintu, Alieu Amara

Clin Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP).
Carolina Herrera, Julianne Lwanga, Ming Lee, Suna Mantori, Alieu Amara

J Antimicrob Chemother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
Sujan Dilly Penchala, Jasmini Alagaratnam, Elizabeth Challenger, Alieu Amara, Laura Else

Biomed Chromatogr· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman.
Cornelia Feiterna-Sperling, Renate Krüger, Alieu Amara, Saye Khoo, Catriona Waitt

AIDS· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
Catriona Waitt, Catherine Orrell, Stephen Walimbwa, Yashna Singh, Kenneth Kintu, Alieu Amara

PLoS Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine".
Stephen Walimbwa, Mohammed Lamorde, Catriona Waitt, Alieu Amara, Saye Khoo

Antimicrob Agents Chemother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
Emilie R Elliot, Maddalena Cerrone, Elizabeth Challenger, Laura Else, Alieu Amara

J Antimicrob Chemother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
Stephen I Walimbwa, Mohammed Lamorde, Catriona Waitt, Julian Kaboggoza, Laura Else, Alieu Amara

Antimicrob Agents Chemother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
Emilie R Elliot, Maddalena Cerrone, Elizabeth Challenger, Laura Else, Alieu Amara

J Antimicrob Chemother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk.
Joshua Gini, Sujan Dilly Penchala, Alieu Amara, Elizabeth Challenger, Deirdre Egan

Bioanalysis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39).
Arkaitz Imaz, Jordi Niubó, Alieu Amara, Saye Khoo, Elena Ferrer

J Neurovirol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
Alieu B Amara, Laura J Else, Dianne Carey, Saye Khoo, David J Back

Ther Drug Monit· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
Catriona Waitt, Sujan Diliiy Penchala, Adeniyi Olagunju, Alieu Amara, Laura Else

J Chromatogr B Analyt Technol Biomed Life Sci· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
Emilie R Elliot, Alieu Amara, Nicole Pagani, Laura Else, Graeme Moyle

J Antimicrob Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
Emilie R Elliot, Alieu Amara, Nicole Pagani, Laura Else, Graeme Moyle

J Antimicrob Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma.
Sujan Dilly Penchala, Sandra Fawcett, Laura Else, Deirdre Egan, Alieu Amara

J Chromatogr B Analyt Technol Biomed Life Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis